Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Unveiling Significance of Time in Range: Value as key Glycemic Biomarker

Need to redefine the treatment paradigm Post OAD

The Evolving Role of Treatment and Technology in Diabetes Care

Time-in-Range: A Key Determinant of Quality of Life

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

What Are the Signs and Symptoms of ASMD?

EVOLUTION: RWE from Saudi Arabia

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Gaucher

Navigating the Pompe Disease Journey

Recognizing Key Signs and Symptoms Along the Way

Impact of symptoms and risk of ASMD on patients and caregivers

Differential diagnostics for ASMD in patients suspected to have GD